Improving antiplatelet therapy uptake: lessons from the Scottish experience

Cardiovascular disease remains the leading cause of death worldwide.1,2 Advances in management strategies have, however, reduced population-level mortality rates for certain cardiovascular conditions over the past several decades, such as for coronary artery disease.3 As part of these advances, the use of effective therapies such as antiplatelet therapies (APT) has increased substantially over time in […]

Read More…

System-level initiatives to reduce persistently elevated blood pressures in hypertensive patients: how do we overcome clinical inertia?

In the United States, research consistently shows around half of adults with hypertension do not achieve recommended control of their blood pressure (BP).1 Poor BP control at the population level then leads to higher rates of preventable negative cardiovascular outcomes, like strokes and heart attacks. As recently reported, Elizabeth Pfoh and colleagues studied a quality […]

Read More…